Information Links
Mims
Main Navigation
Drugs
Conditions
ArticlesLicence Changes & Product Updates
Long-acting anticholinergic licensed for childhood asthma
Spiriva Respimat (tiotropium) is now licensed for use...
Capsule inhalation warning for tiotropium inhaler
Train patients prescribed Braltus (tiotropium) in the...
PCSK9 inhibitor licensed for risk reduction in established cardiovascular disease
Repatha (evolocumab) can now be prescribed to reduce...
Diabetes test strips recalled
Patients with diabetes who use the Accu-Chek Aviva...
Valproate banned in women not on Pregnancy Prevention Programme
Valproate can no longer be used in women or girls of...
MS treatment to be withdrawn over safety concerns
The European Medicines Agency (EMA) has recommended...
Sildenafil to be available over the counter
Men with erectile dysfunction (ED) will be able to...
Prescribe quinine with caution in patients at risk of QT prolongation, MHRA advises
New advice highlights that quinine can have effects...
Risk of serious skin reactions with anaemia drugs
Severe cutaneous adverse reactions can occur in patients...
Clozapine prescribers reminded of intestinal obstruction risk
Clozapine can impair intestinal peristalsis, leading...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
